Latest Capital Raises News

Wia Gold Limited reports strong drilling results at its Kokoseb Gold Project in Namibia and advances exploration in Côte d'Ivoire, backed by a A$30 million capital raise to fund an expanded 2025 development program.

Aura Energy has reported a substantial 49% increase in Ore Reserves at its flagship Tiris Uranium Project, advancing towards a Final Investment Decision in early 2025 while also benefiting from positive regulatory shifts in Sweden.

Rox Resources has advanced its Youanmi Gold Project with a $27 million capital raise and a major drilling campaign, positioning the company for production by late 2025.

Empire Energy Group Limited reported a significant cash outflow of $14.2 million in the December 2024 quarter, driven by exploration and evaluation activities, yet maintains a strong liquidity position with nearly $54 million in available funding.

Viking Mines has unveiled a high-grade inferred mineral resource of 19,000 ounces at its historic First Hit Gold Mine, alongside ongoing drilling and a strong cash position following a recent capital raise.

Sprintex has locked in A$30 million in distribution agreements across the UK, Turkiye, and India, while advancing its innovative G25 Jet Blower launch, signaling a strong growth trajectory in energy-efficient technologies.

Aurora Labs has secured significant contracts in the Defence sector, advancing its micro gas turbine technology and expanding production capabilities following a successful capital raise.

Kincora Copper Limited has unveiled an updated investor presentation outlining its aggressive push towards Tier-1 copper-gold discoveries, backed by over $60 million in partner funding and ramped-up drilling programs across New South Wales and Mongolia.

Complii FinTech Solutions Ltd reports a robust Q2 FY25 with a $3.048 million cash balance, a net operational cash inflow, and a 12.9% year-on-year increase in Annual Recurring Revenue, driven by strategic divestment and focused growth initiatives.

Thor Energy PLC advances its clean energy ambitions through a strategic acquisition in South Australia's hydrogen sector and promising uranium drilling results in the US.

Zelira Therapeutics has received a fourth funding tranche, bringing total investment to US$3.25 million to support FDA clinical trials of its HOPE® 1 cannabinoid medicine targeting irritability in autism spectrum disorder and Phelan-McDermid Syndrome.

Imperial Pacific Limited reports a $652,000 net gain for the half year ending December 31, 2024, driven by strong investment performance and an increased dividend, despite ongoing challenges with its Excelsior Capital stake.